Carotid Stenotic Scan Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

Carotid Stenotic Scan Devices Market by Product Type (Ultrasound, CT Angiography (CTA) Systems, Magnetic Resonance Angiography (MRA) Systems, and Others), End-User (Hospitals, Diagnostic Imaging Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the growing prevalence of vascular & cerebrovascular diseases and increasing product development and launches activities by key players.

The carotid stenotic scan devices market is estimated to grow at a CAGR of 5.31% during the forecast period from 2025 to 2032. The demand for carotid stenotic scan devices is being driven by the rising prevalence of vascular and cerebrovascular diseases such as carotid stenosis, carotid artery disease, and stroke. Additionally, the shift toward minimally invasive diagnostic procedures and the increasing product development and launch activities by key market players are creating a favorable environment for market growth. These factors are expected to drive the market growth of the carotid stenotic scan devices market during the forecast period from 2025 to 2032.

Carotid Stenotic Scan Devices Market Dynamics:

According to the British Heart Foundation (2024), an estimated 640 million people worldwide were living with heart and circulatory conditions, a number that continues to rise due to the combined impact of sedentary lifestyles and a rapidly aging global population. As of 2022, some of the most widespread cardiovascular diseases (CVDs) worldwide include coronary (ischemic) heart disease, affecting more than 250 million people; peripheral arterial disease, with an estimated 110 million cases; stroke, impacting nearly 94 million individuals; and atrial fibrillation, which affected approximately 53 million people globally. Such cardiovascular disease is a leading cause of plaque buildup in arterial walls, leading to the development of carotid stenosis. Therefore, rising cases of cardiovascular diseases are driving the market growth.

According to the British Heart Foundation (2024), an estimated 56 million women and 45 million men worldwide are stroke survivors, highlighting the substantial global burden of cerebrovascular disease. Additionally, in 2022, nearly 250 million people globally were living with coronary heart disease, underscoring the urgent need for effective diagnostic and interventional solutions. The World Stroke Organization (2023) further emphasized that one in four adults over the age of 25 is expected to suffer a stroke in their lifetime, with over 110 million individuals worldwide already affected. Stroke often results from carotid stenosis. Carotid stenotic imaging devices play a crucial role in preventing carotid artery stenosis, thereby propelling the market growth.

Furthermore, the rise in risk factors such as aging populations and hypertension is contributing to the increased incidence of carotid stenosis. According to the World Health Organization (2023), approximately 1.28 billion adults aged 30-79 were living with hypertension globally, with two-thirds residing in low- and middle-income countries. Elevated blood pressure damages arterial walls and promotes plaque buildup, which can lead to carotid artery narrowing. This rising burden of hypertension is further propelling the growth of the carotid stenotic scan devices market.

However, the high equipment and procedure costs and stringent regulatory requirements for product approval, among others, are some of the key constraints that may limit the growth of the carotid stenotic scan devices market.

Carotid Stenotic Scan Devices Market Segment Analysis:

Carotid Stenotic Scan Devices Market by Product Type (Ultrasound, CT Angiography (CTA) Systems, Magnetic Resonance Angiography (MRA) Systems, and Others), End-User (Hospitals, Diagnostic Imaging Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the carotid stenotic scan devices market, the ultrasound devices category is estimated to account for the largest market share in 2024. The growth of the category is primarily driven by the rising incidence of carotid artery stenosis and the clinical advantages that ultrasound offers in the diagnosis of these conditions. Ultrasound, especially carotid duplex ultrasound, is the most widely used technique in the diagnosis of carotid stenosis, as ultrasound is the first-line imaging modality for evaluating carotid artery stenosis.

Among imaging modalities, carotid duplex ultrasound stands out as the most widely used and preferred technique for the evaluation of carotid stenosis. As the first-line imaging modality, ultrasound offers real-time, non-invasive assessment of both arterial wall structure, including plaque, calcification, dissection, and hemodynamics, such as blood flow velocity, turbulence, and aliasing at stenotic sites.

Doppler ultrasound, in particular, provides direct visualization and measurement of blood flow through the carotid arteries, enabling accurate assessment of stenosis severity. It also allows immediate detection of abnormal flow patterns, which are critical for early diagnosis and treatment planning. Importantly, carotid ultrasound is radiation-free and non-invasive, making it safe for repeated use, especially in elderly patients and those at high risk for stroke or vascular complications.

For example, the Vscan Air SL by GE HealthCare is a notable ultrasound device designed for rapid cardiovascular and vascular assessments, including the evaluation of carotid artery stenosis. Its portability and ease of use further enhance the accessibility of carotid diagnostics across a variety of care settings.

In summary, the combination of clinical efficacy, safety, accessibility, and technological innovation is expected to significantly boost the ultrasound segment, thereby contributing to the overall growth of the carotid stenotic scan devices market worldwide.

North America is expected to dominate the overall carotid stenotic scan devices market:

North America is projected to hold the largest share of the carotid stenotic scan devices market in 2024, driven by several key factors. This dominance is driven by the rising prevalence of vascular and cerebrovascular diseases, along with a growing shift toward minimally invasive diagnostic procedures. The region also benefits from a well-established healthcare infrastructure and the strong presence of leading market players, which enhances product availability and adoption. Together, these factors firmly position North America as the leading market share in the global carotid stenotic scan devices market.

According to data from the National Institutes of Health (2021), an estimated 327,721 individuals in the U.S. have high-grade carotid stenosis. Carotid stenotic scan devices play a critical role in the early and accurate diagnosis of these conditions, making them essential in clinical practice.

The growing number of carotid stenosis cases is a major factor driving market growth in the region. Additionally, the increasing prevalence of hypertension, a key risk factor for carotid stenosis, is further fueling demand. As reported by Million Hearts Organization (2023), nearly half of U.S. adults, i.e., approximately 119.9 million, had hypertension. High blood pressure can damage artery walls and promote plaque buildup, leading to carotid artery narrowing.

The rising burden of these risk factors is significantly boosting the need for effective diagnostic tools like carotid stenotic scan devices. Furthermore, the North American market benefits from the strong presence of major industry players such as GE HealthCare and Siemens Healthineers AG, who are actively promoting and distributing their devices across the region.

Collectively, the rising burden of cardiovascular disease, combined with strong industry support and healthcare capabilities, is propelling the demand for carotid stenotic scan devices in North America, reinforcing its position as a leading region in the global market.

Carotid Stenotic Scan Devices Market Key Players:

Some of the key market players operating in the carotid stenotic scan devices market include GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers AG, Canon Inc., Hitachi, Ltd., Samsung, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Fujifilm Holdings Corporation, Shimadzu Corporation, Hologic, Inc., Esaote SpA, Analogic Corporation, MicroPort Scientific Corporation, Bracco Imaging, Neusoft, United Imaging Healthcare Co., Ltd., Shanghai Pulse Medical Technology Inc., NIPRO, CONAVI MEDICAL, Insight Lifetech Co., Ltd., and others.

Recent Developmental Activities in the Carotid Stenotic Scan Devices Market:

• In April 2025, Siemens Healthineers launched two new imaging systems, MAGNETOM Flow and SOMATOM Pro. Pulse. MAGNETOM Flow, a next-generation MRI system, is particularly valuable in neurology, offering highly detailed imaging for the early detection of conditions such as stroke and neurodegenerative diseases. Combined with SOMATOM Pro. Pulse, a cutting-edge CT system, these technologies enhance diagnostic capabilities and support more accurate, early intervention.
• In November 2023, Philips launched its next-generation ultrasound systems EPIQ Elite and Affiniti, designed to enhance the detection of stroke risk and carotid artery stenosis. These advanced systems offer improved imaging capabilities and diagnostic precision, supporting clinicians in early and accurate vascular assessments.
• In August 2023, GE HealthCare introduced the Vscan Air SL, a wireless handheld ultrasound device designed for rapid cardiac and vascular assessments. Equipped with a dual-headed probe, the device features both a sector array and a linear array, allowing clinicians to easily switch between focused cardiac and vascular imaging using a single device, enhancing speed and flexibility in patient care.

Key takeaways from the carotid stenotic scan devices market report study

• Market size analysis for the current carotid stenotic scan devices market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the carotid stenotic scan devices market.
• Various opportunities available for the other competitors in the carotid stenotic scan devices market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current carotid stenotic scan devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for the carotid stenotic scan devices market growth in the future?

Target audience who can benefit from this carotid stenotic scan device market report study

• Carotid stenotic scan device product providers
• Research organizations and consulting companies
• Carotid stenotic scan devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in carotid stenotic scan devices
• Various end-users who want to know more about the carotid stenotic scan devices market and the latest technological developments in the carotid stenotic scan devices market.

Frequently Asked Questions for the Carotid Stenotic Scan Devices Market:

1. What are carotid stenotic scan devices?

• Carotid stenotic scan devices are medical imaging systems used to detect and evaluate narrowing (stenosis) in the carotid arteries, which supply blood to the brain. These devices help assess stroke risk and guide treatment decisions.

2. What is the market for carotid stenotic scan devices?

• The carotid stenotic scan devices market is estimated to grow at a CAGR of 5.31% during the forecast period from 2025 to 2032.

3. What are the drivers for the carotid stenotic scan devices market?

• The demand for carotid stenotic scan devices is being driven by the rising prevalence of vascular and cerebrovascular diseases such as carotid stenosis, carotid artery disease, and stroke. Additionally, the shift toward minimally invasive diagnostic procedures and the increasing product development and launch activities by key market players are creating a favorable environment for market growth. These factors are expected to support the steady and robust expansion of the carotid stenotic scan devices market from 2025 to 2032.

4. Who are the key players operating in the carotid stenotic scan devices market?

• Some of the key market players operating in the carotid stenotic scan devices market include GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers AG, Canon Inc., Hitachi, Ltd., Samsung, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Fujifilm Holdings Corporation, Shimadzu Corporation, Hologic, Inc., Esaote SpA, Analogic Corporation, MicroPort Scientific Corporation, Bracco Imaging, Neusoft, United Imaging Healthcare Co., Ltd., Shanghai Pulse Medical Technology Inc., NIPRO, CONAVI MEDICAL, Insight Lifetech Co., Ltd., and others.

5. Which region has the highest share in the carotid stenotic scan devices market?

• North America is projected to hold the largest share of the carotid stenotic scan devices market in 2024, driven by several key factors. This dominance is driven by the rising prevalence of vascular and cerebrovascular diseases, along with a growing shift toward minimally invasive diagnostic procedures. The region also benefits from a well-established healthcare infrastructure and the strong presence of leading market players, which enhances product availability and adoption. Together, these factors firmly position North America as the leading market share in the global carotid stenotic scan devices market.

This product will be delivered within 2 business days.